UA95103C2 - Замещенные арилсульфонамиды в качестве противовирусных средств - Google Patents

Замещенные арилсульфонамиды в качестве противовирусных средств

Info

Publication number
UA95103C2
UA95103C2 UAA200811582A UAA200811582A UA95103C2 UA 95103 C2 UA95103 C2 UA 95103C2 UA A200811582 A UAA200811582 A UA A200811582A UA A200811582 A UAA200811582 A UA A200811582A UA 95103 C2 UA95103 C2 UA 95103C2
Authority
UA
Ukraine
Prior art keywords
antiviral agents
substituted arylsulfonamides
arylsulfonamides
preparation
substituted
Prior art date
Application number
UAA200811582A
Other languages
English (en)
Ukrainian (uk)
Inventor
Нильс Свенструп
Хольгер Циммерманн
Дагмар КАРТХАУС
Андреас Гьоллер
Дирк Хаймбах
Керстин Хеннингер
Дитер Ланг
Даниэла Паульсен
Бернд Ридль
Рудольф Шоэ-Лооп
Йоахим Шумахер
Тобиас Вунберг
Original Assignee
Аикурис Гмбх & Ко. Кг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38180640&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UA95103(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Аикурис Гмбх & Ко. Кг filed Critical Аикурис Гмбх & Ко. Кг
Publication of UA95103C2 publication Critical patent/UA95103C2/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/73—Unsubstituted amino or imino radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

В заявке описаны замещенные арилсульфонамиды формулы (I) и способы их получения, а также их применение для приготовления лекарственных средств, предназначенных для лечения и/или профилактики заболеваний, особенно применения как противовирусных средств, преимущественно для борьбы с цитомегаловирусами.(I)
UAA200811582A 2006-03-03 2007-02-26 Замещенные арилсульфонамиды в качестве противовирусных средств UA95103C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102006009928A DE102006009928A1 (de) 2006-03-03 2006-03-03 Substituierte Arylsulfonamide

Publications (1)

Publication Number Publication Date
UA95103C2 true UA95103C2 (ru) 2011-07-11

Family

ID=38180640

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200811582A UA95103C2 (ru) 2006-03-03 2007-02-26 Замещенные арилсульфонамиды в качестве противовирусных средств

Country Status (26)

Country Link
US (1) US8318761B2 (ru)
EP (1) EP1991529B1 (ru)
JP (1) JP5255455B2 (ru)
KR (1) KR101447758B1 (ru)
CN (1) CN101389607B (ru)
AR (1) AR059710A1 (ru)
AT (1) ATE451356T1 (ru)
AU (1) AU2007222689B2 (ru)
BR (1) BRPI0707068A2 (ru)
CA (1) CA2642602C (ru)
DE (2) DE102006009928A1 (ru)
DK (1) DK1991529T3 (ru)
ES (1) ES2335316T3 (ru)
IL (1) IL193449A (ru)
JO (1) JO2581B1 (ru)
MX (1) MX2008011264A (ru)
PE (1) PE20080136A1 (ru)
PL (1) PL1991529T3 (ru)
PT (1) PT1991529E (ru)
PY (1) PY0705508A (ru)
RU (1) RU2423352C2 (ru)
TW (1) TWI388559B (ru)
UA (1) UA95103C2 (ru)
UY (1) UY30178A1 (ru)
WO (1) WO2007101573A1 (ru)
ZA (1) ZA200807189B (ru)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10319612A1 (de) 2003-05-02 2004-11-18 Bayer Healthcare Ag Substituierte Dihydrochinazoline
EP2103316A1 (de) * 2008-03-20 2009-09-23 Bayer MaterialScience AG Hydrophile Polyurethandispersionen
EP2103318A1 (de) * 2008-03-20 2009-09-23 Bayer MaterialScience AG Medizinische Geräte mit hydrophilen Beschichtungen
EP2103317A1 (de) * 2008-03-20 2009-09-23 Bayer MaterialScience AG Medizinische Geräte mit hydrophilen Beschichtungen
EP2103638A1 (de) * 2008-03-20 2009-09-23 Bayer MaterialScience AG Hydrophile Polyurethanlösungen
DE102008025614A1 (de) * 2008-05-28 2009-12-03 Bayer Materialscience Ag Hydrophile Polyurethanbeschichtungen
DE102008025613A1 (de) * 2008-05-28 2009-12-03 Bayer Materialscience Ag Hydrophile Polyurethanbeschichtungen
US8791200B2 (en) 2008-09-04 2014-07-29 Bayer Materialscience Ag TCD based hydrophilic polyurethane dispersions
DE102011101446A1 (de) * 2011-05-10 2012-11-15 Aicuris Gmbh & Co. Kg Herstellung von "Dense Bodies" (DB)
EP2853532B1 (en) * 2013-09-28 2020-12-09 Instytut Farmakologii Polskiej Akademii Nauk 1,2,4-oxadiazole derivatives as allosteric modulators of metabotropic glutamate receptors belonging to group III
CN109879817B (zh) * 2019-03-19 2020-10-02 扬州大学 甲基二磺隆的制备方法
RU2738848C1 (ru) * 2019-10-24 2020-12-17 Общество с ограниченной ответственностью "Научно-исследовательский институт ХимРар" (ООО "НИИ ХимРар") Ингибитор вируса гепатита В (ВГВ), представляющий собой производные N-{ 3-[6-(диалкиламино)пиридазин-3-ил]фенил} арилсульфонамида и производные N-{ 4-[6-(диалкиламино)пиридазин-3-ил]фенил} арилсульфонамида

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19802437A1 (de) 1998-01-23 1999-07-29 Bayer Ag Verwendung von substituierten Sulfonamiden als anitvirale Mittel und neue Stoffe
EP1172361A4 (en) 1999-04-19 2002-05-08 Shionogi & Co SULFONAMIDE DERIVATIVES HAVING OXADIAZOLE CORES
DE19920790A1 (de) * 1999-05-06 2000-11-09 Bayer Ag Bis-Sulfonamide mit anti-HCMV-Wirkung
DE19930075A1 (de) 1999-06-30 2001-01-04 Bayer Ag Neue Amino- und Amidosulfonamide als antivirale Mittel
DE50204780D1 (de) 2001-04-19 2005-12-08 Bayer Healthcare Ag Arylsulfonamide als antivirale mittel
DE10138578A1 (de) 2001-08-06 2003-02-27 Bayer Ag Heterocyclylarylsulfonamide

Also Published As

Publication number Publication date
US20090176842A1 (en) 2009-07-09
TW200813034A (en) 2008-03-16
MX2008011264A (es) 2008-09-12
PL1991529T3 (pl) 2010-05-31
JP2009529016A (ja) 2009-08-13
US8318761B2 (en) 2012-11-27
PY0705508A (es) 2013-01-01
PE20080136A1 (es) 2008-04-18
ATE451356T1 (de) 2009-12-15
RU2008139195A (ru) 2010-04-10
BRPI0707068A2 (pt) 2011-04-19
CA2642602C (en) 2014-05-13
DK1991529T3 (da) 2010-04-12
IL193449A0 (en) 2009-05-04
DE502007002264D1 (de) 2010-01-21
CN101389607B (zh) 2011-09-07
JO2581B1 (en) 2011-02-27
CA2642602A1 (en) 2007-09-13
AU2007222689B2 (en) 2011-11-17
KR20080107456A (ko) 2008-12-10
KR101447758B1 (ko) 2014-10-06
CN101389607A (zh) 2009-03-18
AR059710A1 (es) 2008-04-23
PT1991529E (pt) 2010-01-06
AU2007222689A1 (en) 2007-09-13
EP1991529B1 (de) 2009-12-09
JP5255455B2 (ja) 2013-08-07
ZA200807189B (en) 2009-12-30
HK1125371A1 (zh) 2009-08-07
RU2423352C2 (ru) 2011-07-10
EP1991529A1 (de) 2008-11-19
TWI388559B (zh) 2013-03-11
WO2007101573A1 (de) 2007-09-13
IL193449A (en) 2013-02-28
ES2335316T3 (es) 2010-03-24
DE102006009928A1 (de) 2007-09-06
UY30178A1 (es) 2007-09-28

Similar Documents

Publication Publication Date Title
UA95103C2 (ru) Замещенные арилсульфонамиды в качестве противовирусных средств
NL300933I2 (nl) Letermovir
EA200802213A1 (ru) Способы лечения заболеваний крови
SV2009003299A (es) Derivados de dihidropiridina de utilidad como inhibidores de la proteina quinasa
EA200870193A1 (ru) Цитотоксические агенты, включающие новые производные томаймицина, и их терапевтическое применение
MY140826A (en) Substituted pyrazoline compounds, their preparation and use as medicaments.
EA201190217A1 (ru) Замещенные 2-ацетамидо-5-арил-1,2,4-триазолоны и их применение
TN2010000137A1 (en) Spiropyrrolidines and their use against hcv and hiv infection
TNSN08400A1 (en) Organic compounds and their uses
EA201290267A1 (ru) Производные диоксабицикло[3.2.1]октан-2,3,4-триола
UA106367C2 (ru) Производные азадиспиро[3.0.4.1]декана и их применение
UA85559C2 (en) Aminobenzophenone compounds
CL2007002384A1 (es) Uso de compuestos derivados de 2,5-dihidroxibenceno para el tratamiento de la psoriasis.
TW200745043A (en) Substituted pyrazoline compounds, their preparation and use as medicaments
CL2007002380A1 (es) Uso de compuestos derivados de 2,5-dihidroxibenceno para el tratamiento terapeutico y/o profilactico de la queratosis actinica.
PT2056804E (pt) Utilização de derivados de 2,5-di-hidroxibenzeno para o tratamento de doenças oculares
MA32841B1 (fr) Composés de cycloundeca depsipeptides et leur utilisation comme médicament
MX2009010374A (es) Derivados de tetrahidro-naftalenamina sustituidos con heterociclilo, su preparacion y su uso como medicamentos.
NO20074780L (no) Heterocyklylamidsubstituerte imidazoler
JO2999B1 (ar) مركب ثلاثي حلقي و استخدامه الدوائي
TW200738699A (en) 4-Substituted pyrazoline compounds, their preparation and use as medicaments
ATE508125T1 (de) Triazoloanilinopyrimidinderivate zur verwendung als antivirale mittel
ATE380188T1 (de) Substituierte chinolone
MX2010001303A (es) Compuestos terapeuticos.
UY30135A1 (es) Quinolonas sustituidas iii